On the other hand, blocking angiotensin II formation by angiotensin-converting enzyme (ACE) inhibitors can inhibit atherogenesis [17] and prevent cardiovascular events (e.g., myocardial infarction, stroke and cardiovascular mortality) [18]. The gene discussed is ACE; the disease is myocardial infarction.